Fox Christine (CIK 1998173) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-04). Recent activity: Sell TEVA (21,258 shares), Buy TEVA (17,819 shares), Sell TEVA (7,924 shares), Buy TEVA (20,461 shares), Sell TEVA (9,098 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-04 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | EVP, U.S. Commercial | Sell | 21,258 | $750,620 |
| 2026-03-09 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | EVP, U.S. Commercial | Buy | 17,819 | $0 |
| 2026-03-09 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | EVP, U.S. Commercial | Sell | 7,924 | $250,953 |
| 2026-03-06 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | EVP, U.S. Commercial | Buy | 20,461 | $0 |
| 2026-03-06 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | EVP, U.S. Commercial | Sell | 9,098 | $295,321 |
| 2025-11-24 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | EVP, Head of U.S. Commercial | Buy | 63,492 | $0 |
| 2025-11-24 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | EVP, Head of U.S. Commercial | Sell | 28,229 | $699,515 |
| 2025-11-18 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | EVP, Head of U.S. Commercial | Sell | 30,000 | $753,300 |
Source: SEC Form 4 filings · as of 2026-05-04